1. Home
  2. PMVP vs FCO Comparison

PMVP vs FCO Comparison

Compare PMVP & FCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMVP
  • FCO
  • Stock Information
  • Founded
  • PMVP 2013
  • FCO 1991
  • Country
  • PMVP United States
  • FCO United Kingdom
  • Employees
  • PMVP N/A
  • FCO N/A
  • Industry
  • PMVP Medicinal Chemicals and Botanical Products
  • FCO Investment Managers
  • Sector
  • PMVP Health Care
  • FCO Finance
  • Exchange
  • PMVP Nasdaq
  • FCO Nasdaq
  • Market Cap
  • PMVP 85.5M
  • FCO 79.9M
  • IPO Year
  • PMVP 2020
  • FCO N/A
  • Fundamental
  • Price
  • PMVP $1.51
  • FCO $5.91
  • Analyst Decision
  • PMVP Strong Buy
  • FCO
  • Analyst Count
  • PMVP 4
  • FCO 0
  • Target Price
  • PMVP $5.75
  • FCO N/A
  • AVG Volume (30 Days)
  • PMVP 196.4K
  • FCO 100.1K
  • Earning Date
  • PMVP 11-07-2024
  • FCO 01-01-0001
  • Dividend Yield
  • PMVP N/A
  • FCO 14.96%
  • EPS Growth
  • PMVP N/A
  • FCO N/A
  • EPS
  • PMVP N/A
  • FCO 0.43
  • Revenue
  • PMVP N/A
  • FCO N/A
  • Revenue This Year
  • PMVP N/A
  • FCO N/A
  • Revenue Next Year
  • PMVP N/A
  • FCO N/A
  • P/E Ratio
  • PMVP N/A
  • FCO $12.30
  • Revenue Growth
  • PMVP N/A
  • FCO N/A
  • 52 Week Low
  • PMVP $1.40
  • FCO $4.73
  • 52 Week High
  • PMVP $3.47
  • FCO $6.63
  • Technical
  • Relative Strength Index (RSI)
  • PMVP 38.59
  • FCO 50.28
  • Support Level
  • PMVP $1.55
  • FCO $5.82
  • Resistance Level
  • PMVP $1.61
  • FCO $6.09
  • Average True Range (ATR)
  • PMVP 0.07
  • FCO 0.08
  • MACD
  • PMVP -0.01
  • FCO -0.00
  • Stochastic Oscillator
  • PMVP 18.18
  • FCO 49.89

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

About FCO abrdn Global Income Fund Inc.

abrdn Global Income Fund Inc is a closed-end, non-diversified management investment company. The Fund's principal investment objective is to provide high current income by investing predominantly in fixed-income securities. As a secondary investment objective, the Fund seeks capital appreciation, but only when consistent with its principal investment objective. It invests in Government Bonds & Corporate Bonds, and its investments are divided into three categories, Developed Markets, Investment Grade Developing Markets, and Sub-Investment Grade Developing Markets.

Share on Social Networks: